WALTHAM, Mass., Feb. 02, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences taking place in February 2016.
- LEERINK Partners 5th Annual Global Healthcare Conference
Presentation: Wednesday, February 10, 2016 at 8:00 a.m. ET*
One-on-one meetings: Wednesday, February 10, 2016
Location: New York, NY - RBC Capital Markets Healthcare Conference 2016
Presentation: Wednesday, February 24, 2016 at 8:30 a.m. ET*
One-on-one meetings: Wednesday, February 24, 2016
Location: New York, NY
*A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com, and will be archived for 30 days.
About AMAG
AMAG Pharmaceuticals uses its business and clinical expertise to develop and commercialize products that provide clear benefits and improve people’s lives. Based in Waltham, MA, AMAG has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. AMAG continues to work to expand the impact of these and future products for patients by delivering on its growth strategy, which includes organic growth, as well as the pursuit of products and companies that align with AMAG’s existing therapeutic areas or those that could benefit from its proven core competencies. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc.